Company: FENC
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001558370-25-005563
Chunk: 19

Company: FENNEC PHARMACEUTICALS INC.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 19
---
 (or such other minimum and maximum for such offering period as may be specified by the Administrator) of such grantee’s base salary (excluding incentive pay, bonuses or raises) during the applicable offering period, as elected by the grantee at the time of enrollment or as herein provided, on a pro rata basis per pay period; (ii) a one-time lump sum payment per offering period as elected by the grantee upon giving at least five business days’ notice to the Corporation; or (iii) a combination of payments pursuant to (i) and (ii). Notwithstanding any other provisions of the Equity Incentive Plan or an Award Certificate, each grantee shall be subject to an annual contribution limit respecting Stock Purchase Rights of US$25,000. |

| • | Purchase Price. The purchase price at which Shares may be purchased pursuant to Stock Purchase Rights shall be determined by the Administrator, provided that such purchase price shall not be less than the lesser of: (i) 85% of the fair market value of the Shares on the applicable offering commencement date; and (ii) 85% of the fair market value of the Shares on the last day of the applicable offering period. |

| • | Sale Event. In the case of a sale of the Corporation, the acquiring corporation or its parent, as the case may be, may without the consent of any grantee assume the Corporation’s rights and obligations respecting Stock Purchase Rights granted under the Equity Incentive Plan. If such acquiring corporation elects not to assume the Corporation’s rights and obligations respecting Stock Purchase Rights granted under the Equity Incentive Plan, the expiry of the then current offering period shall be accelerated to a date before the date of the Corporation sale specified by the Administrator. All Stock Purchase Rights which are neither assumed by the acquiring corporation or its parent in connection with a sale of the Corporation, nor exercised as of the date of such Corporation sale, shall terminate and cease to be outstanding effective as of the date of the Corporation sale. |

| • | Tax Qualification. Although the Corporation will endeavor to qualify Stock Purchase Rights for favorable tax treatment under Section 423 of the Code and avoid adverse tax treatment (e.g., under Section 409A of the Code), the Corporation makes no representation to that effect and expressly disavows any covenant to maintain favorable or avoid unfavorable tax treatment, anything to the contrary in the Equity Incentive Plan notwithstanding. The Corporation shall be unconstrained in its corporate activities without regard to the potential negative tax impact on Stock Purchase Right